Results 161 to 170 of about 1,680,012 (219)

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

open access: yesAdvanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun   +23 more
wiley   +1 more source

Arbovirus surveillance and bloodmeal analysis in mosquito species from Northern Kenya

open access: yes
Akengo HA   +15 more
europepmc   +1 more source

Evaluation and comparison of three qPCR commercial assays and three automated platforms for the detection of monkeypox virus DNA. [PDF]

open access: yesMicrobiol Spectr
Usal M   +8 more
europepmc   +1 more source

Malectin Alleviates Endoplasmic Reticulum Stress in Gestational Diabetes Mellitus via Glycoprotein Quality Control Mechanisms

open access: yesAdvanced Science, EarlyView.
Malectin alleviates high glucose‐induced ER stress and damage in placental trophoblasts, a function dependent on its six critical carbohydrate‐binding residues. In a GDM mouse model, administration of TAT‐Malectin ameliorated hyperglycemia and placental ER stress and prevented fetal macrosomia.
Jiahui Zhu   +12 more
wiley   +1 more source

Expanding diversity of tick-borne phleboviruses (Phlebovirus mukawaense, Mudanjiang phlebovirus, Gomselga Virus, and Onega tick phlebovirus) in Russia. [PDF]

open access: yesPLoS One
Kartashov MY   +8 more
europepmc   +1 more source

TIM-1 promotes infection with mosquito cell-derived alphaviruses through virion-associated phospholipids. [PDF]

open access: yesEmerg Microbes Infect
Yoo JE   +9 more
europepmc   +1 more source

Modeled Scenario Projections for the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026. [PDF]

open access: yesMMWR Morb Mortal Wkly Rep
Mooring EQ   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy